Impress employers and recruiters.
Choose from hundreds of resume examples.
Impress employers and recruiters.
Choose from hundreds of resume examples.
Tailor your resume to this Associate Director, Marketing role.
Rezi rewrites your resume against Lexeo Therapeutics's job description. Free.
Tailor your resume to this Associate Director, Marketing role.
Rezi rewrites your resume against Lexeo Therapeutics's job description. Free.
Don't guess if your resume is good enough.
See how it scores against the Associate Director, Marketing posting at Lexeo Therapeutics — free, in seconds.
Don't guess if your resume is good enough.
See how it scores against the Associate Director, Marketing posting at Lexeo Therapeutics — free, in seconds.
About the Role
This role is central to preparing for the launch of LX2006, Lexeo’s first commercial product, and will also support early commercial planning for LX2006. It offers a highly visible, hands-on opportunity to build a launch from the ground up and shape the commercial foundation of a growing company.
Responsibilities
- Partner with the Senior Director, Marketing to enhance and execute the LX2006 US launch strategy and brand plan.
- Serve as a core member of the cross-functional US and ex-US Launch Readiness Teams, driving launch timelines and deliverables.
- Lead the HCP, patient/caregiver, and payer research program for LX2006.
- Own the Friedreich ataxia (FA) competitive intelligence program.
- Lead global brand development for LX2006, including brand naming and identity, and develop and deploy unbranded disease-awareness and branded HCP and patient campaigns.
- Build and refine the prescriber, account and treatment center universe and define targeting and segmentation.
- Develop and execute the commercial HCP and KOL engagement plan.
- Support ex-US launch sequencing and go-to-market planning.
- Develop core launch materials and contribute to field training and launch meeting planning.
- Support early commercial planning for LX2020, including target product profile development and market sizing.
- Manage marketing budgets, statements of work, and vendor relationships.
- Help scale the team and contribute to a collaborative cross-functional commercial mindset culture.
Requirements
- MBA or other advanced degree required.
- Minimum of 7 years of experience in the biopharmaceutical industry, including direct marketing experience on a launch brand and/or in rare disease.
- Demonstrated experience developing brand strategy, positioning and HCP and/or patient campaigns, including agency management and MLR review.
- Hands-on experience designing and managing primary market research and translating insights into strategy.
- Strong analytical skills, with comfort working with claims and other secondary data, forecasts and market sizing.
- Exceptional project management skills and a proven ability to lead cross-functional teams without direct authority.
- Excellent written and verbal communication skills.
- Working knowledge of US compliance requirements governing pre-approval and promotional activities.
- Self-starter with a builder mindset who thrives in a lean, fast-paced, pre-commercial environment.
- Ability to travel as needed.
Skills
- Gene therapy marketing experience is a plus.
- Gene therapy or cell and gene therapy launch experience (significant plus).
- Prior management or strategy consulting experience in life sciences.
- Experience in cardiology and/or neurology marketing.
- Exposure to market access, pricing and reimbursement for high-cost, one-time therapies.
- Global or ex-US launch experience, including familiarity with HTA requirements.
Location
- Northeast
- Mid-Atlantic
- New York City
Work Type
- Hybrid
Experience Level
- Associate Director
- Minimum of 7 years of experience
Education Level
- MBA or other advanced degree
Salary/Compensations
- $170,000 - $230,000 a year
About the Company
- Lexeo Therapeutics is a New York City-based, clinical stage company dedicated to reshaping the path of genetic disease.
- By advancing pioneering science, Lexeo seeks to set a new standard in the treatment of cardiovascular and neurological genetic diseases, charting the path to patient outcomes once thought out of reach.
- The Company is advancing a portfolio of therapeutic candidates designed to address the underlying genetic causes of disease, including LX2006 for Friedreich ataxia (FA), LX2020 for plakophilin-2 (PKP2) arrhythmogenic cardiomyopathy, and others in devastating diseases with high unmet need.
Equal Opportunity
- LEXEO Therapeutics is an EEO employer committed to an exciting, diverse, and enriching work environment.